INTERNATIONAL
NETWORK FOR ARTIFICIAL CELLS,
BLOOD SUBSTITUTES & BIOTECHNOLOGY (ISABB)
www.medicine.mcgill.ca/artcell
AIMS
OF THIS INTERNATIONAL NETWORK
This
international network was formed in 1976 to encourage research, development and clinical
applications
in artificial cells, blood substitutes, nanomedicine,
regenerative medicine, tissue engineering, cell/stem cell
therapy, hemoperfusion, bioencapsulation, and related areas.
We
have avoided a tight and restrictive organizational structure. Instead responsibilities are
widely
distributed
to committees and organizers of congresses and symposia. This
allows this society to benefit
from
fresh ideas and novel approaches and to move with the frontier of
research. This, plus the enthusiastic participation and voluntary contribution of
members of the society, has allowed us to continue this
international
network for nearly
50 years without charging membership fees – this allows for world-wide
participation with no restrictions related to nationality, age, experience,
financial status. This also avoid
any
one group or groups from controlling the network or preventing it from moving
in the frontier of research.
OFFICERS
OF THE INTERNATIONAL NETWORK
Elected Honorary President
and coordinator: T.M.S.Chang (McGill,
Canada)
Elected Executive
committee (Elected Past-Presidents of of ISABI
congresses and/or symposia):
V.Bonamini(Italy)1978; L.Bulow (Sweden), 2015; C.U.Casciani(Italy)1990; T.M.S.Chang(Canada)1976,
1987,
1991,1996, 2017); ;
K. Kobayashi(Japan) 2003; R.Langer (USA) 1994; Qin Liu (China) 2007; A. Mozzarelli (Italy); Nikolaev(USSR) 1986; E.Piskin(Turkey)1982,2001; A.Trevino Becerra(Mexico) 1985, 2000; ; C.M.Yang(China),
1997; Yang/Sakai (2019).WM Zapol (USA), 2011: Zheng/Yang/Liu (China) 2013
[Late Prof D. Falkenhagen (Austria); Late Prof AG.Greenburg (USA)
2005; Late Prof M.Odaka (Japan); Late Prof
S.Sideman(Israel); Late Prof
E.Tsuchida (Japan); Late
Prof R.Winslow (USA): Late Prof Y.T.Yu(China)]
Subcommittee of
ISABB: International Committee on Blood Substitutes ISBS:
ISBS Executive board members (past elected ISBS presidents or their
representatives):
1987:
Chang (1987, 1991,1996, 2017)
1993: Keipert (for late Winslow 1993, 1999)
1997:
Yang/Yu YT (1997)
1997:
Sakai (for late Tsuchida 1997)
2003:
Kobayashi (2003)
2005: Late Greenberg (2005)
2007:
Liu/Xiu (2007)
2009: Mozzarelli (2009)
2011:
Binglan Yu for Late Prof Zapol (2011)
2013:
Zheng/Liu/Yang (2013)
2015:
Leif Bülow (2015)
2017:
Chang (2017)
2019: Yang/Sakai (2019)
ISBS Scientific Advisory Board
Alayash A, Abuchowski A.
Baumler,H, Bian Y, Biro B, Bucci E, Bülow L, Burhop K, Chang
TMS, Chen C, Cooper C, D’Agnillo F, Estep
T, Feola M, Gould S, , Han JQ,
Hong Z, Intaglietta M, Jahr J,
Keipert P, Kim HW, Kluger R,
Kobayashi K, Krafft MP, Liu Q, Liu JX,
Ma L, Meßmer K, Mozzarelli A,
Palmer A, Privalle C, Pugach I, Rausch
C, Riess JG, Sakai
H, Simoni, Selivanov E, Su ZG, Tsai AG,
Wei G, Wong B, Wong JT, Xiu RJ,
Yang CM, Yu BL, Zafiris G , Zal
. Zapol W, Zhang Y, Zhao L, Zhu
YJW
CONFERENCES
The
emphasis is to concentrate on 1 or 2 areas that need extensive effort towards
routine clinical uses. Once
the
area is in routine clinical use, the area is left to other groups to look after
and we then concentrate on another
1 to
2 areas that needs major effort. Each congress or symposium president in
consultation with his local organizing committee, makes the final decision and
has the final responsibilities including financial responsibilities. After each
congress or symposium, the president or appointed
representative becomes a member of the executive committee of the ISABI.
I 1976 ISABI (I HPS Hemoperfusion
HP) President: TMS Chang (McGill, Canada)
II 1978 ISABI (II HPS) President: V Bonamini (Bologna U, Italy) co-chair
TMS Chang (McGill Canada)
III 1980 ISABI (III HPS) President: S. Sideman
(Technion, Israel) co-chair TMS Chang (McGill Canada)
IV 1982 ISABI
(IV HPS) President: E. Piskin (Ankara U, Turkey) Honorary
President: TMS Chang(Canada)
V 1983 ISABI (V HPS) President:
C Z Huang (President, Chinese Academy of Medical Sciences),
co-chair TMS Chang (McGill Canada)
VI 1985 ISABI (VI HPS) President: A. Trevino Becerra (Mexico). Honorary President: TMS
Chang (Canada)
VII 1986 ISABI (VII
HPS) President: V.Nikolaev(USSR Academy of Sci), Honorary
President: TMS Chang
VIII 1987 ISABI
(III ISBS) President:
TMS Chang (McGill, Canada), Cochair: R.Geyer
(Harvard) 1987
IX 1988
ISABI (VIII HPS) President: D.Falkenhagen & Klinkmann(Germany) Honorary President:TMS
Chang
X 1989 ISABI
(VIV HPS) President: M.Odaka(Chiba U, Japan), Honorary President: TMS
Chang
XI 1990 ISABI (X HPS): President: C.U.Casciani(Rome U, Italy), Cochiar: G Splendiani (Rome U, Italy)
Honorary
President TMS Chang (McGill, Canada)
XII 1991 ISABI (IV
ISBS) President: T.M.S.Chang(McGill, Canada) Cochair R.Geyer (Harvard, USA)
XIII 1993 ISABI (V
ISBS) President: R.Winslow(Letterman, USA) Cochairs:
TMS Chang (McGill, Canada) & R.Riess (France),
1993
XII 1994 ISABI Congress President: R.
Langer (MIT, U.S.A.), Honorary president: TMS Chag
(McGill)
XIII 1996 ISABI (VI ISBS) President:
TMS Chang (McGill, Canada) Cochairs: A.G.Greenberg (Brown
U, U.S.A) & E.Tsuchica (Waseda U, Japan)
XIV 1997 ISABI Congress
President: Denian Ba (President,Academy of
Med Sci, China) & C.M. Yang (CAMS, China), Honorary President TMS Chang
(McGill, Canada)
XV 1997 ISABI
(VII ISBS) President: E.Tsuchida (Waseda U, Japan) Cochairs:
S.Sekiguchi (Red Cross,
Japan) & TMS Chang
(McGill, Canada)
XVI 1999 ISABI (VIII ISBS) President: R.Winslow (UC at San
Diego, U.S.A.) Cochairs: TMS Chang (McGill, Canada), M.Intaglietta(UC at San Diego, U.S.A.)
& E.Tsuchida (Waseda U, Japan)
XV 2001 ISABI Congress President:
E. Piskin (Ankara U, Turkey) Honorary President: TMSChang
(McGill)
XVI 2003 ISABI (IX ISBS) President: K. Kobayashi (Keio
U, Japan), Cochair: E.Tsuchida
(Waseda U, Japan), Honorary President: TMS Chang
(McGill, Canada)
XVII 2005 ISABI
(X ISBS) President:
G. Greenberg (Brown U, U.S.A.) HonoraryPresident:
TMS Chang
XVIII 2007 ISABI (XI ISBS) President: Q. Liu
(Vice-president, Chineswe Academyof Medical Sci., China) Executive
President: R Xiu (Academy of Medical Sci, China),
Honorary President: TMS Chang (McGill)
XIX 2009 ISABI (XII ISBS) President: A. Mozzarelli (University of Parma, Italy), Vice
Presidents Professor Enrico Bucci (University of Maryland)
and Professor
Clara Fronticelli ( Johns Hopkins
University, U.S.A.)
Honorary President: Professor TMS
Chang (McGill University, Canada)
XX 2011 ISABI (XIII ISBS) President: Professor
W Zapol (Harvard Medical
School, U.S.A.)
Honorary President: Professor TMS Chang
(McGill University, Canada)
XXI 2013 ISABI (XIV ISBS) President:
Professor Zheng (BTI China), Vice presidents Professor Liu (BTI China) & Professor Yang
(BIT China), Honorary President, Professor Chang (McGill, Canada)
XXII 2015 ISABI (XV ISBS) President:
Professor L Bulow (Lund, Sweden), Honorary President, Prof TMS Chang
XXIII 2017 ISABI Congress (XVI ISBS, V ISNS) Professor TMS
Chang, 60th
anniversary Conference on Artificial
Cells in conjunction with XVI ISBS and V ISNS (McGill, Canada)
XXIV 2019 (XVII ISBS) China/Japan.
Co-Presidents: Professor CM Yang (BTI CAMS, China) Professor Sakai (Mara,
Japan); Honorary President: Professor TMS Chang (McGill, Canada)
XXV 2022 (XVIII ISBS) Cancelled
because of pandemic
XXV 2004 (XIX ISBS) Co-presidents
J Jahr & A Doctor (Maryland, USA). Honorary
President: Professor TMS Chang (McGill, Canada)
JOURNALS
AND BOOKS
ARTIFICIAL
CELLS, NANOMEDICINE AND BIOTECHNOLOGY, an international
journal (http://www.tandfonline.com/action/showMostReadArticles?journalCode=ianb20 ) Publisher: Frances
& Taylor, U.K.:
This
is a peer review journal that is the oldest journal in the field
having started in
1972
"Biomaterial, Medical Devices & Artificial Organs, an international
journal".
1979:
Chang became the editor in chief and allows the name of the
journal to change with time to reflect the frontier of research in the area.
Before 2003 this journal was "Artificial Cells, Blood
Substitutes and Immobilization Biotechnology").
2003:
Starting in 2003 it was "Artificial Cells Blood Substitutes and
Biotechnology.
2012
it became Artificial
Cells, Nanomedicine and Biotechnology. Its demand is such
that in 2016 the publisher has increased the issues from 6/year to 8/year with
corresponding increase in the total pages that increased to 2,400 submission/year
IN 2020. This has become more than a full-time
job. Furthermore, the publisher has changed this journal to an Open Access
format that no longer allow publications from researchers of a number of
countries. After 40 years as editor in chief this journal is now well established,
he therefore resigned but was invited to stay on as Emeritus editor
Editor in
chief: 1985-2020 TMS
Chang (McGill, Canada) (emeritus editor 2020- ); Coeditors in chief: 2021- D Misra
(USA) W Chrzanowski (Australia) P Roach (U.K.)
Please
see home page: http://www.tandfonline.com/action/showMostReadArticles?journalCode=ianb20
for more details
INTERNATIONAL
JOURNAL OF CELL/TISSUE ENGINEERING, ARTIFICIAL CELLS AND REGENERATIVE MEDICINE,
Editor in chief: TMS Chang (McGill,Canada)
In 2023, World Science Publisher (Official publisher of all the Nobel
Prize Lectures since the beginning) started this new journal
with hybrid Open Access so authors can decide whether they want to pay a fee
for their papers to be open access. They invited me to be editor in chief of
this new journal (I accepted this because it is important not to restrict those
who do not want to pay the high open access fee). I am already the editor in
chief for their book series on REGENERATIVE MEDICINE, ARTIFICIAL CELLS AND NANOMEDICINE
since 2006
BOOK
SERIES ON REGENERATIVE MEDICINE, ARTIFICIAL CELLS AND
NANOMEDICINE http://www.medicine.mcgill.ca/artcell/1%20book%20series.pdf
(World Science Publisher/Imperial College Press)
Editor in chief: TMS Chang (McGill,Canada)
Volume 1: Monograph
by TMS Chang “ARTIFICIAL CELLS: Biotechnology, Nanomedicine, Regenerative
Medicine, Blood
Substitutes, Bioencapsulation and Cell-Stem Cell Therapy”
Chang 2007 454 pages with full text. Now available free on www.medicine.mcgill.ca/artcell
Volume 2: Present and
future Therapies for End-Stage Renal Failure. Editors: Eli
Friedman & MC Mallappallil (2010)
Volume 3:
Selected Topics in Nanomedicine. Editor: TMS Chang (2013)
Volume 4: Hemoperfusion and plasma-perfusion: general,
selective, immune and leucocyte adsorbents.
Editors: TMS Chang, Y Endo, VG Nikolaev, T Tani, YT Yu and WH Zheng (2017)
Chapter 1 available on www.medicine.mcgill.ca/artcell
Volume
5: Nanobiotherapeutic
blood substitute and oxygen-based therapeutics
Editor in chief: TMS Chang, Coeditors: L Bulow, J Jahr, H Sakai
& CM Yang) (2021). available free on www.medicine.mcgill.ca/artcell
Volume 6: Monograph
By TMS Chang (2nd edition): “ARTIFICIAL
CELLS: Biotechnology, Nanomedicine, Regenerative Medicine, Blood
Substitutes, Immunotheraputics,
Bioencapsulation and Cell-Stem Cell Therapy” (in preparation)
WEBSITE
The
Web Site of this international network: www.medicine.mcgill.ca/artcell
There
is a RELATED SITES LINKAGE on our home page to available sites of related
groups around the world. Please send us your website for others to learn
about your research activities and your publications.